BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35107768)

  • 21. Monocyte mimics improve mesenchymal stem cell-derived extracellular vesicle homing in a mouse MI/RI model.
    Zhang N; Song Y; Huang Z; Chen J; Tan H; Yang H; Fan M; Li Q; Wang Q; Gao J; Pang Z; Qian J; Ge J
    Biomaterials; 2020 Oct; 255():120168. PubMed ID: 32562944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Vital Roles of Mesenchymal Stem Cells and the Derived Extracellular Vesicles in Promoting Angiogenesis After Acute Myocardial Infarction.
    Zhang LL; Xiong YY; Yang YJ
    Stem Cells Dev; 2021 Jun; 30(11):561-577. PubMed ID: 33752473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MSC-Derived Extracellular Vesicles in Preclinical Animal Models of Bone Injury: A Systematic Review and Meta-Analysis.
    Kirkham AM; Bailey AJM; Tieu A; Maganti HB; Montroy J; Shorr R; Campbell TM; Fergusson DA; Lalu MM; Elmoazzen H; Allan DS
    Stem Cell Rev Rep; 2022 Mar; 18(3):1054-1066. PubMed ID: 34313927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular vesicles enriched with miR-150 released by macrophages regulates the TP53-IGF-1 axis to alleviate myocardial infarction.
    Zheng S; Gong M; Chen J
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H969-H979. PubMed ID: 33164579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol.
    Barron CC; Lalu MM; Stewart DJ; Fergusson D; Yang H; Moher D; Liu P; Mazer D; Devereaux PJ; McIntyre L;
    Syst Rev; 2017 Nov; 6(1):226. PubMed ID: 29116020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction.
    Chen CW; Wang LL; Zaman S; Gordon J; Arisi MF; Venkataraman CM; Chung JJ; Hung G; Gaffey AC; Spruce LA; Fazelinia H; Gorman RC; Seeholzer SH; Burdick JA; Atluri P
    Cardiovasc Res; 2018 Jun; 114(7):1029-1040. PubMed ID: 29566124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal Stem Cell Exosomes for Cartilage Regeneration: A Systematic Review of Preclinical
    Tan SSH; Tjio CKE; Wong JRY; Wong KL; Chew JRJ; Hui JHP; Toh WS
    Tissue Eng Part B Rev; 2021 Feb; 27(1):1-13. PubMed ID: 32159464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal Stem Cell-Derived Extracellular Vesicles in Tendon and Ligament Repair-A Systematic Review of In Vivo Studies.
    Lu V; Tennyson M; Zhang J; Khan W
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic potential of stem cell extracellular vesicles for ischemic stroke in preclinical rodent models: a meta-analysis.
    Zhao J; Deng H; Xun C; Chen C; Hu Z; Ge L; Jiang Z
    Stem Cell Res Ther; 2023 Apr; 14(1):62. PubMed ID: 37013588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-101a loaded extracellular nanovesicles as bioactive carriers for cardiac repair.
    Wang J; Lee CJ; Deci MB; Jasiewicz N; Verma A; Canty JM; Nguyen J
    Nanomedicine; 2020 Jul; 27():102201. PubMed ID: 32278100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in sepsis: a Systematic Review and Meta-Analysis of Preclinical Studies.
    Aghayan AH; Mirazimi Y; Fateh K; Keshtkar A; Rafiee M; Atashi A
    Stem Cell Rev Rep; 2024 May; ():. PubMed ID: 38814410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
    Chen J; Zhan Y; Wang Y; Han D; Tao B; Luo Z; Ma S; Wang Q; Li X; Fan L; Li C; Deng H; Cao F
    Acta Biomater; 2018 Oct; 80():154-168. PubMed ID: 30218777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular vesicles from human embryonic stem cell-derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis.
    Wu Q; Wang J; Tan WLW; Jiang Y; Wang S; Li Q; Yu X; Tan J; Liu S; Zhang P; Tiang Z; Chen Z; Foo RS; Yang HT
    Cell Death Dis; 2020 May; 11(5):354. PubMed ID: 32393784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of cardiac function by mesenchymal stem cells derived extracellular vesicles through targeting miR-497/Smad7 axis.
    Chen M; Chen J; Li C; Yu R; Chen W; Chen C
    Aging (Albany NY); 2021 Sep; 13(18):22276-22285. PubMed ID: 34528899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extruded Mesenchymal Stem Cell Nanovesicles Are Equally Potent to Natural Extracellular Vesicles in Cardiac Repair.
    Wang X; Hu S; Li J; Zhu D; Wang Z; Cores J; Cheng K; Liu G; Huang K
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55767-55779. PubMed ID: 34793116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. M1 Bone Marrow-Derived Macrophage-Derived Extracellular Vesicles Inhibit Angiogenesis and Myocardial Regeneration Following Myocardial Infarction via the MALAT1/MicroRNA-25-3p/CDC42 Axis.
    Chen B; Luo L; Wei X; Gong D; Li Z; Li S; Tang W; Jin L
    Oxid Med Cell Longev; 2021; 2021():9959746. PubMed ID: 34745428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac Progenitor Cell-Derived Extracellular Vesicles Reduce Infarct Size and Associate with Increased Cardiovascular Cell Proliferation.
    Maring JA; Lodder K; Mol E; Verhage V; Wiesmeijer KC; Dingenouts CKE; Moerkamp AT; Deddens JC; Vader P; Smits AM; Sluijter JPG; Goumans MJ
    J Cardiovasc Transl Res; 2019 Feb; 12(1):5-17. PubMed ID: 30456736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Systematic Review and Meta-Analysis: Safety and Efficacy of Mesenchymal Stem Cells Therapy for Heart Failure.
    Shen T; Xia L; Dong W; Wang J; Su F; Niu S; Wang Q; Fang Y
    Curr Stem Cell Res Ther; 2021; 16(3):354-365. PubMed ID: 32867655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemokine stromal cell-derived factor 1/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction.
    Zhuang Y; Chen X; Xu M; Zhang LY; Xiang F
    Chin Med J (Engl); 2009 Jan; 122(2):183-7. PubMed ID: 19187644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma-derived extracellular vesicles from myocardial infarction patients inhibits tumor necrosis factor-alpha induced cardiac cell death.
    Khandagale A; Lindahl B; Lind SB; Shevchenko G; Siegbahn A; Christersson C
    Curr Res Transl Med; 2022 May; 70(2):103323. PubMed ID: 34979484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.